BSE filing, NSE: TRU. Summary written from the filing by ALFA Finder's alert engine.
TruCap Finance Ltd: key numbers
- Share price
- ₹3.94
- Market cap
- ₹47.19 Cr
- Revenue (annual)
- ₹82.54 Cr
- Net profit (annual)
- ₹-112.7 Cr
- P/E (TTM)
- -0.5×Sector 19.7×
- Promoter holding
- 30.73%-0.23% QoQ
- FII holding
- 4.98%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from TruCap Finance Ltd
All →TruCap Finance Management Change
TruCap Finance designated three employees as Senior Management Personnel, effective 29 October 2026. The changes are additional charges for Product, Operations and Contact Centre roles.
TruCap Finance Q2 FY27 Results: Net Loss of ₹11.6 Cr, Loss Narrows
TruCap Finance Ltd reported revenue from operations of ₹12.3 Cr (-46.1% YoY) and a net loss of ₹11.6 Cr for Q2 FY27.
- Key figure
- Net loss ₹11.6 Cr
TruCap Finance Board Meeting Date
TruCap Finance schedules a 28 October 2026 board meeting on results, fundraising, an ESOP plan and a postal ballot. Agenda items remain proposals.
TruCap Finance Other Announcement
TruCap Finance Ltd filed its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
TruCap Finance Open Offer
TruCap Finance disclosed a procedural update on the open offer by Marwadi Chandarana. The SAT granted additional time for the appellant's rejoinder, with the next hearing set for November 3, 2026.
TruCap Finance Management Change
TruCap Finance Limited announced the resignation of Mr. Vishal Miglani as Senior Vice President – Business Loans, Cross Sell, Collaborations & Strategy, effective September 20, 2026.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date